KCNQ2 and Tinnitus: Application of retigabine at day 4 significantly reduced the percentage of mice that developed tinnitus (Figure 3F; ‘Materials and methods’), suggesting that the recovery of KCNQ2/3 currents between day 4 and 7 is crucial for tinnitus resilience.